 |
|
|
| |
|
|
|
|
|
|
EIS on Immunology
|
All mediaPlease select a day:
Expand All Hide All
|
|
|
|
EDU |
Thu 15 Nov 16:15 - 17:00 |
Keynote Lecture |
|
Session Chair: John Wagstaff, GB /
| Lecture title |
Speaker |
|
| Cancer immunotherapy: how have we got to where we are now? |
John Wagstaff, GB |
|
|
EDU |
Thu 15 Nov 17:15 - 19:30 |
Cancer and inflammation |
|
Session Chair: Arjan W. Griffioen, NL / Session Co-Chair: Joachim Schultze, DE
| Lecture title |
Speaker |
|
| The inflammatory tumour microenvironment and its impact on cancer development. |
Karin de Visser, NL |
|
| Anti-angiogenic agents: the interface between the immune system and the tumor |
Arjan W. Griffioen, NL |
|
| Tumor induced immune suppression: role of oxidative stress |
Rolf Kiessling, SE |
|
|
EDU |
Fri 16 Nov 08:30 - 10:40 |
T cell immunity versus tolerance |
|
Session Chair: Thomas Blankenstein, DE / Session Co-Chair: Dmitry Gabrilovich, US
| Lecture title |
Speaker |
|
| Measuring T cell responses |
Pedro Romero, CH |
|
| Combining chemotherapy with immunotherapy |
Dmitry Gabrilovich, US |
|
|
EDU |
Fri 16 Nov 11:00 - 13:10 |
Antibodies |
|
Session Chair: Hakan Mellstedt, SE / Session Co-Chair: Carl Borrebaeck, SE
| Lecture title |
Speaker |
|
| Individual idiotype vaccines in hematological malignancies |
Hakan Mellstedt, SE |
|
| HER-2neu vaccines for breast, ovarian and prostate cancers |
George Peoples, US |
|
|
EDU |
Fri 16 Nov 14:10 - 16:20 |
Vaccines I |
|
Session Chair: Rik Scheper, NL / Session Co-Chair: Angus Dalgleish, GB
| Lecture title |
Speaker |
|
| Adjuvants |
Hyam I. Levitsky, US |
|
|
EDU |
Sat 17 Nov 09:00 - 10:40 |
Adoptive Immunotherapy |
|
Session Chair: Michael Papamichail, GR / Session Co-Chair: Hans-Gustaf Ljunggren, SE
| Lecture title |
Speaker |
|
| NK cell activation and tumor recognition |
Hans-Gustaf Ljunggren, SE |
|
| Prospects for adoptive NK cell therapy of human cancer |
Karl Johan Malmberg, SE |
|
| Graft versus tumor and donor lymphocyte infusions |
Shimon Slavin, IL |
|
|
EDU |
Sat 17 Nov 11:00 - 13:15 |
Vaccines II |
|
Session Chair: Carl Figdor, NL / Session Co-Chair: Rik Scheper, NL
| Lecture title |
Speaker |
|
| Dendritic cell vaccines |
Carl Figdor, NL |
|
| Whole cell vaccines |
Rik Scheper, NL |
|
| Viral and vector vaccines |
Joerg Schneider, FR |
|
| Old problems, new directions |
Eli Gilboa, US |
|
|
| |
|
|
|
|
|
|
|
|
| |
|
 |
 |
|
 |
|